Quyn Rahman, MD
Dermatopathology · Brentwood, TNNPI 1972790681
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 34.7% of the total.
Across 61 payments — averaging $17.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$375
- Novartis$211
- E.r. Squibb & Sons, L.L.C.$72
- Incyte Corporation$53
- Regeneron Healthcare Solutions, Inc.$51
- Botanix SB Inc$37
- plus $283 from 12 others
What the payments were for
- Food & beverage$1,082100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 22 | $375 |
| Novartis | 12 | $211 |
| E.r. Squibb & Sons, L.L.C. | 2 | $72 |
| Incyte Corporation | 3 | $53 |
| Regeneron Healthcare Solutions, Inc. | 2 | $51 |
| Botanix SB Inc | 2 | $37 |
| Johnson & Johnson | 3 | $35 |
| Pfizer | 2 | $33 |
| Galderma Laboratories, L.p. | 2 | $32 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $31 |
| Almirall LLC | 2 | $27 |
| Kyowa Kirin, Inc. | 1 | $24 |
| Amgen | 1 | $21 |
| Boehringer Ingelheim | 1 | $17 |
| DUSA Pharmaceuticals, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| Sun Pharmaceutical Industries Inc. | 1 | $16 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $12 |
How this compares
$1,082 in reported general payments places this provider in the 60th percentile of 20 dermatopathology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 16 | $341,154 |
| Dupixent PenDupilumab | 14 | $57,685 |
| Fluorouracil | 97 | $7,690 |
| Triamcinolone Acetonide | 264 | $2,512 |
| Fluocinonide | 73 | $2,099 |
| Metronidazole | 29 | $1,506 |
| Ketoconazole | 133 | $1,479 |
| Doxycycline Hyclate | 71 | $1,414 |
| Minoxidil | 133 | $1,065 |
| Clobetasol Propionate | 47 | $1,041 |
| ValacyclovirValacyclovir Hcl | 47 | $855 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 20 | $763 |
| Clindamycin Phosphate | 12 | $548 |
| Imiquimod | 15 | $496 |
| Terbinafine Hcl | 18 | $202 |
Paid to pharmacies, not to this prescriber.
Other dermatopathology in Brentwood
- Larissa ChismarBrentwood$1K
- Olena DorokhovaBrentwood$109
- Petra MildeBrentwood$37
- Michael LeeBrentwood$35
- Agne NaujokasBrentwood$23
- John HuberMemphis$11K
- Frances BeardMemphis$9K
- Frances LawheadMemphis$9K
- Dallas ProvenceMemphis$8K
- Robin Friedman-MusicanteMemphis$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.